内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-19 · 构建时间： 2026-10-19 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Guardian Pharmacy Services, Inc.

GRDN · NYSE · CIK 0001802255 · Healthcare · Medical Care Facilities

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

20 同一窗口内观察到的 Form 4 交易行
0 sales · 20 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2025-12-03 · COSLER STEVEN D · $99.8K

为什么没有活跃信号？

买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后，这些模块才会启用。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Patchett Mary SueDirector
○
COSLER STEVEN DDirector
○
LEWIS RANDALL JDirector
○
Mudd William FranklinSee Remarks
○
Weir RobertSee Remarks
○
Ackerman JohnDirector,Other
○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 13 additional owner(s) remain in Form 4 申报证据.

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-12-03 · COSLER STEVEN D.

近期 Form 4 活动

1买入
10卖出
34其他 Form 4 交易行
42SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他20 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
2,480,634
上期报告
2,427,722
日均成交量
810,875
回补天数
3.1

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2025-12-03COSLER STEVEN D买入 (P)Class A Common Stock3,370USD 29.61USD 99,786SEC 申报 ↗
2024-11-19COSLER STEVEN D买入 (P)Class A Common Stock7,000USD 21.22USD 148,540SEC 申报 ↗
2024-09-27Salentine Thomas J Jr买入 (P)Class A Common Stock35,714USD 14.00USD 499,996SEC 申报 ↗
2024-09-27Patchett Mary Sue买入 (P)Class A Common Stock3,571USD 14.00USD 49,994SEC 申报 ↗
2024-09-27LEWIS RANDALL J买入 (P)Class A Common Stock3,571USD 14.00USD 49,994SEC 申报 ↗
2024-09-27COSLER STEVEN D买入 (P)Class A Common Stock7,142USD 14.00USD 99,988SEC 申报 ↗

Form 4 申报证据

45 transaction lines in the latest 365-day window; 95 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-27Weir Robert期权行权／转换 (M)Class A Common Stock23,450USD —USD —SEC 申报 ↗
2026-09-27Tuch Jeffrey期权行权／转换 (M)Class A Common Stock55,578USD —USD —SEC 申报 ↗
2026-09-27Towns Douglas期权行权／转换 (M)Class A Common Stock23,450USD —USD —SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-27Weir Robert期权行权／转换 (M)Class A Common Stock23,450USD —USD —SEC 申报 ↗
2026-09-27Tuch Jeffrey期权行权／转换 (M)Class A Common Stock55,578USD —USD —SEC 申报 ↗
2026-09-27Towns Douglas期权行权／转换 (M)Class A Common Stock23,450USD —USD —SEC 申报 ↗
2026-09-27Salentine Thomas J Jr期权行权／转换 (M)Class A Common Stock6,100,175USD —USD —SEC 申报 ↗
2026-09-27Pharmacy Investors, LLC期权行权／转换 (M)Class A Common Stock1,413,939USD —USD —SEC 申报 ↗
2026-09-27Mudd William Franklin期权行权／转换 (M)Class A Common Stock38,282USD —USD —SEC 申报 ↗
2026-09-27Morris David K期权行权／转换 (M)Class A Common Stock641,870USD —USD —SEC 申报 ↗
2026-09-27Martin David Norman期权行权／转换 (M)Class A Common Stock39,865USD —USD —SEC 申报 ↗
2026-09-27Forbes Kendall期权行权／转换 (M)Class A Common Stock608,570USD —USD —SEC 申报 ↗
2026-09-27Eakins Richard期权行权／转换 (M)Class A Common Stock36,052USD —USD —SEC 申报 ↗
2026-09-27Crisafulli Chris期权行权／转换 (M)Class A Common Stock18,931USD —USD —SEC 申报 ↗
2026-09-27Cardinal Equity Fund, L.P.期权行权／转换 (M)Class A Common Stock471,057USD —USD —SEC 申报 ↗
2026-09-27Burke Fred期权行权／转换 (M)Class A Common Stock1,298,825USD —USD —SEC 申报 ↗
2026-09-27Bindley Capital Partners I, LLC期权行权／转换 (M)Class A Common Stock6,100,175USD —USD —SEC 申报 ↗
2026-09-27BINDLEY WILLIAM E期权行权／转换 (M)Class A Common Stock6,100,175USD —USD —SEC 申报 ↗
2026-09-27Ackerman John期权行权／转换 (M)Class A Common Stock1,884,996USD —USD —SEC 申报 ↗
2026-05-05Patchett Mary Sue奖励／授予 (A)Class A Common Stock4,028USD 0.00USD 0SEC 申报 ↗
2026-05-05LEWIS RANDALL J奖励／授予 (A)Class A Common Stock4,028USD 0.00USD 0SEC 申报 ↗
2026-05-05COSLER STEVEN D奖励／授予 (A)Class A Common Stock4,028USD 0.00USD 0SEC 申报 ↗
2026-03-28Salentine Thomas J Jr期权行权／转换 (M)Class A Common Stock6,100,175USD —USD —SEC 申报 ↗
2026-03-28Pharmacy Investors, LLC期权行权／转换 (M)Class A Common Stock1,413,939USD —USD —SEC 申报 ↗
2026-03-28Morris David K期权行权／转换 (M)Class A Common Stock641,869USD —USD —SEC 申报 ↗
2026-03-28Forbes Kendall期权行权／转换 (M)Class A Common Stock608,570USD —USD —SEC 申报 ↗
2026-03-28Cardinal Equity Fund, L.P.期权行权／转换 (M)Class A Common Stock471,057USD —USD —SEC 申报 ↗
2026-03-28Burke Fred期权行权／转换 (M)Class A Common Stock1,298,826USD —USD —SEC 申报 ↗
2026-03-28Bindley Capital Partners I, LLC期权行权／转换 (M)Class A Common Stock6,100,175USD —USD —SEC 申报 ↗
2026-03-28BINDLEY WILLIAM E期权行权／转换 (M)Class A Common Stock6,100,175USD —USD —SEC 申报 ↗
2026-03-28Ackerman John期权行权／转换 (M)Class A Common Stock1,884,996USD —USD —SEC 申报 ↗
2026-03-20Salentine Thomas J Jr卖出 (S)Class A Common Stock3,570,677USD 29.68USD 105,977,693SEC 申报 ↗
2026-03-20Pharmacy Investors, LLC卖出 (S)Class A Common Stock827,636USD 29.68USD 24,564,236SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-19
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码GRDN
CIK0001802255
行业Healthcare
细分行业Medical Care Facilities Yahoo Finance
SEC SIC5912 Retail-Drug Stores and Proprietary Stores
交易所NYSE

数据覆盖

本地 Form 4 历史95 transaction lines from 2024-09-27 to 2026-09-27
6 P purchase lines · 30 S sale lines · 59 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.